Document is current
Any future updates will be listed below
-
Authors
Zacariaz Hereter, Johana
Rosa, Javier Eduardo
Mollerach, Florencia Beatriz
Marin, Josefina
Ferreyra Garrott, Leandro Gabriel
Brom, Martin
Soriano, Enrique Roberto
-
Funding
Funding for this research was provided by:
this study was supported by an unrestricted grant from pan american league of rheumatology associations
- License Information
-
More Information
Article History
Received: 27 July 2021
Revised: 5 January 2022
Accepted: 21 January 2022
First Online: 1 February 2022
Compliance with ethical standards
:
: The study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice guidelines. The protocol received the approval of the local ethics committee (CEPI, Comité de Ética de Protocolos de Investigación). The data obtained about patients while participating in the study was encrypted, as well as the related health records, and remained strictly confidential at all times. Only researchers had access to personal information of the patients.
: All participants signed an informed consent before being included in the study.
: Not applicable.
: Johana Zacariaz Hereter reports: grant support from Bristol-Myers Squibb.Javier Eduardo Rosa reports: advisory board member, speaker, or grant support from Abbvie, Pfizer, Eli Lilly, Bristol Novartis, Amgen.Florencia Mollerach, Josefina Marin, Leandro Gabriel Ferreyra Garrott declare non conflict of interest.Martin Brom is employee at Novartis Switzerland (post study performed).Enrique Roberto Soriano reports: advisory board member, speaker, or grant support from AbbVie, Amgen, Bristol-Myers Squibb, GSK, Genzyme, Janssen, Lilly, Novartis, Pfizer, Roche, Sandoz, Sanofi, UCB.
